Autologous graft-versus-host disease: A novel approach for antitumor immunotherapy
- 31 July 1992
- journal article
- review article
- Published by Elsevier in Human Immunology
- Vol. 34 (3) , 219-224
- https://doi.org/10.1016/0198-8859(92)90115-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Interferon-γ Potentiates the Antitumor Effect of Cyclosporine-Induced AutoimmunityJournal of Hematotherapy, 1992
- Cyclosporine induced syngeneic graft-vs-host disease: An immunotherapeutic approach after autologous bone marrow transplantationThe International Journal of Cell Cloning, 1992
- IMMUNE MECHANISMS IN CYCLOSPORINE-INDUCED SYNGENEIC GRAFT-VERSUS-HOST DISEASETransplantation, 1989
- Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor PrognosisNew England Journal of Medicine, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Graft‐versus‐Host Reactions and DiseaseImmunological Reviews, 1985
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979